| Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice PK Dash, R Kaminski, R Bella, H Su, S Mathews, TM Ahooyi, C Chen, ... Nature communications 10 (1), 1-20, 2019 | 289 | 2019 |
| Creation of a long-acting nanoformulated dolutegravir B Sillman, AN Bade, PK Dash, B Bhargavan, T Kocher, S Mathews, H Su, ... Nature communications 9 (1), 443, 2018 | 110 | 2018 |
| Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles T Zhou, H Su, P Dash, Z Lin, BLD Shetty, T Kocher, A Szlachetka, ... Biomaterials 151, 53-65, 2018 | 93 | 2018 |
| HIV-1 cellular and tissue replication patterns in infected humanized mice M Araínga, H Su, LY Poluektova, S Gorantla, HE Gendelman Scientific reports 6 (1), 23513, 2016 | 71 | 2016 |
| Immune activations and viral tissue compartmentalization during progressive HIV-1 infection of humanized mice H Su, Y Cheng, S Sravanam, S Mathews, S Gorantla, LY Poluektova, ... Frontiers in immunology 10, 418920, 2019 | 21 | 2019 |
| In vivo killing of primary HIV-infected cells by peripheral-injected early memory–enriched anti-HIV duoCAR T cells K Anthony-Gonda, A Ray, H Su, Y Wang, Y Xiong, D Lee, A Block, ... JCI insight 7 (21), 2022 | 14 | 2022 |
| CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice PK Dash, C Chen, R Kaminski, H Su, P Mancuso, B Sillman, C Zhang, ... Proceedings of the National Academy of Sciences 120 (19), e2217887120, 2023 | 13 | 2023 |
| T cell receptor–targeted immunotherapeutics drive selective in vivo HIV-and CMV-specific T cell expansion in humanized mice M Li, SJ Garforth, KE O’Connor, H Su, DM Lee, A Celikgil, RJ Chaparro, ... The Journal of Clinical Investigation 131 (23), 2021 | 12 | 2021 |
| Pathways towards human immunodeficiency virus elimination PK Dash, BD Kevadiya, H Su, MG Banoub, HE Gendelman EBioMedicine 53, 2020 | 12 | 2020 |
| Amplification of replication competent HIV-1 by adoptive transfer of human cells from infected humanized mice H Su, S Sravanam, S Gorantla, R Kaminski, K Khalili, L Poluektova, ... Frontiers in Cellular and Infection Microbiology 10, 38, 2020 | 8 | 2020 |
| Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice. Nat Commun 10: 2753 PK Dash, R Kaminski, R Bella, H Su, S Mathews, TM Ahooyi, C Chen, ... | 8 | 2019 |
| Recovery of latent HIV-1 from brain tissue by adoptive cell transfer in virally suppressed humanized mice H Su, S Sravanam, B Sillman, E Waight, E Makarov, S Mathews, ... Journal of Neuroimmune Pharmacology, 1-10, 2021 | 7 | 2021 |
| HIV-1-associated left ventricular cardiac dysfunction in humanized mice PK Dash, FA Alomar, BT Hackfort, H Su, A Conaway, LY Poluektova, ... Scientific reports 10 (1), 9746, 2020 | 7 | 2020 |
| Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice. Nat Commun. 2019; 10: 2753 PK Dash, R Kaminski, R Bella, H Su, S Mathews, TM Ahooyi | 6 | |
| Identification of tissue HIV-1 reservoirs in infected humanized mice H Su, P Dash, L Poluektova, S Gorantla, H Gendelman JOURNAL OF NEUROIMMUNE PHARMACOLOGY 13, S83-S83, 2018 | 1 | 2018 |
| Accelerated Neuroimmune Dysfunction in Aged HIV-1-Infected Humanized Mice C Zhang, H Su, E Waight, LY Poluektova, S Gorantla, HE Gendelman, ... Pharmaceuticals 17 (2), 149, 2024 | | 2024 |
| IND-Enabling Studies Towards an Open Phase I/IIa Trial to Evaluate the Safety and Efficacy of Anti-HIV DuoCAR-T Cell Therapy K Anthony-Gonda, A Ray, H Su, S Kleinsorge-Block, L Zemelko, Y Wang, ... MOLECULAR THERAPY 30 (4), 373-374, 2022 | | 2022 |
| ALCOHOL POTENTIATES CLEARANCE OF HIV-INFECTED HEPATOCYTES: IS IT BENEFICIAL? M Ganesan, M New-Aaron, E Makarov, RS Dagur, H Su, KK Kharbanda, ... HEPATOLOGY 70, 1232A-1232A, 2019 | | 2019 |
| HIV-1 Elimination in Humanized Mice H Su | | 2019 |
| P-A8 Establishing tissue reservoirs for the human immunodeficiency virus in humanized mice H Su, P Dash, S Gorantla, L Poluektova, H Gendelman JAIDS Journal of Acquired Immune Deficiency Syndromes 77, 55, 2018 | | 2018 |
Howard E. GendelmanProfessor and Chair, Pharmacology & Experimental Neuroscience, University of Nebraska Medical CenterBestätigte E-Mail-Adresse bei unmc.edu
